96 related articles for article (PubMed ID: 7627143)
1. Early detection of amphotericin B induced nephrotoxicity by 99mTc-DTPA: a useful test.
Sawas-Dimopoulou C; Papathanassiou P; Margaritis L
Nucl Med Biol; 1995 Apr; 22(3):297-301. PubMed ID: 7627143
[TBL] [Abstract][Full Text] [Related]
2. Must we really fear toxicity of conventional amphotericin B in oncological patients?
Mayer J; Doubek M; Vorlìcek J
Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice.
Tonomura Y; Yamamoto E; Kondo C; Itoh A; Tsuchiya N; Uehara T; Baba T
Hum Exp Toxicol; 2009 May; 28(5):293-300. PubMed ID: 19661263
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM
Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033
[TBL] [Abstract][Full Text] [Related]
5. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
[TBL] [Abstract][Full Text] [Related]
7. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats.
Wasan KM; Vadiei K; Lopez-Berestein G; Luke DR
J Infect Dis; 1990 Mar; 161(3):562-6. PubMed ID: 2313133
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
[TBL] [Abstract][Full Text] [Related]
10. Glomerular filtration rate estimated from the uptake phase of 99mTc-DTPA renography in chronic renal failure.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Nephrol Dial Transplant; 1999 Jul; 14(7):1673-8. PubMed ID: 10435875
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic effects of flucytosine on amphotericin B nephrotoxicity in rats.
Heidemann HT; Brune KH; Sabra R; Branch RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2670-5. PubMed ID: 1482135
[TBL] [Abstract][Full Text] [Related]
12. Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules.
Bernardo JF; Murakami S; Branch RA; Sabra R
Nephron; 1995; 70(2):235-41. PubMed ID: 7566310
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic assessment of renal function in steel plant workers occupationally exposed to lead.
Wrońska-Nofer T; Pisarska A; Trzcinka-Ochocka M; Hałatek T; Stetkiewicz J; Braziewicz J; Nofer JR; Wąsowicz W
J Occup Health; 2015; 57(2):91-9. PubMed ID: 25735505
[TBL] [Abstract][Full Text] [Related]
14. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B.
Thanki K; Prajapati R; Sangamwar AT; Jain S
Int J Pharm; 2018 Jun; 544(1):1-13. PubMed ID: 29635057
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B.
Kato H; Hagihara M; Yamagishi Y; Shibata Y; Kato Y; Furui T; Watanabe H; Asai N; Koizumi Y; Mikamo H
J Infect Chemother; 2018 Sep; 24(9):725-728. PubMed ID: 29773439
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
17. Quantitative renal scintigraphic determination of the glomerular filtration rate in cats with normal and abnormal kidney function, using 99mTc-diethylenetriaminepentaacetic acid.
Uribe D; Krawiec DR; Twardock AR; Gelberg HB
Am J Vet Res; 1992 Jul; 53(7):1101-7. PubMed ID: 1497177
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B.
Hossain MA; Maesaki S; Razzaque MS; Tomono K; Taguchi T; Kohno S
J Antimicrob Chemother; 2000 Aug; 46(2):263-8. PubMed ID: 10933650
[TBL] [Abstract][Full Text] [Related]
19. [Quantification of separate renal function using Tc 99m DTPA and Tc 99m DMSA. Correlations between individual isotopic data and creatinine clearance].
Chevet D; Moisan A; Le Pogamp P; Le Cloirec J; Wehbe B; Herry JY
Nephrologie; 1984; 5(1):21-5. PubMed ID: 6328339
[TBL] [Abstract][Full Text] [Related]
20. Study of the toxicity of a new lipid complex formulation of amphotericin B.
Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
